Skip to main content
logo
Anixa Biosciences logo
Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.900
-0.010 (-0.34%)
Oct 9, 2026, 4:00 PM EDT - Market closed

Anixa Biosciences Cash Flow Statement

Millions USD. Fiscal year is Nov - Oct.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Net Income
-10.38-10.93-12.55-9.81-13.6-12.95
Depreciation & Amortization
0.040.040.040.050.040.06
Loss (Gain) From Sale of Assets
------0.01
Loss (Gain) From Sale of Investments
0.01-0.14----
Stock-Based Compensation
3.043.814.84.746.758.06
Other Operating Activities
-0.09-0.1-0.14-0.12-0.18-0.17
Change in Accounts Receivable
-0.170.1-0.22-0.03-
Change in Accounts Payable
0.01-0.360.32-0.060.13-0.1
Change in Other Net Operating Assets
-0.340.11-0.780.390.17
Operating Cash Flow
-7.38-7.17-7.34-6.21-6.49-4.94
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Sale of Property, Plant & Equipment
-----0.04
Investment in Securities
2.064.874.28-5.6-10.73-3.96
Investing Cash Flow
2.064.874.28-5.6-10.73-3.92

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Issuance of Common Stock
5.412.393.420.370.4531.57
Repurchase of Common Stock
---0.01---
Other Financing Activities
-0.19-0.11----
Financing Cash Flow
5.222.283.420.370.4531.57

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Net Cash Flow
-0.1-0.030.36-11.45-16.7722.71

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Free Cash Flow
-7.38-7.17-7.34-6.21-6.49-4.94
Free Cash Flow Growth
------
Free Cash Flow Margin
----2956.67%--964.45%
Free Cash Flow Per Share
-0.22-0.22-0.23-0.20-0.21-0.17
Levered Free Cash Flow
-3.74-3.29-3-3.02-1.260.04
Unlevered Free Cash Flow
-3.74-3.29-3-3.02-1.260.04

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Change in Working Capital
0.010.150.53-1.060.490.08
SEC Filings: 10-K · 10-Q